Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This umbrella review aimed to evaluate the efficacy and safety of vitamin D supplementation as an adjunctive treatment for asthma and to assess the credibility of the existing evidence.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Efficacy and safety of vitamin D in the treatment of asthma: an overview of systematic reviews and meta-analyses

Source: Article title.

This study was designed as an umbrella review, also known as an overview of systematic reviews.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Efficacy and safety of vitamin D in the treatment of asthma: an overview of systematic reviews and meta-analyses

Systematic review · Frontiers in Medicine · 2026

Original publication title

Efficacy and safety of vitamin D in the treatment of asthma: an overview of systematic reviews and meta-analyses

Yongxiu Liu; Jiaheng Lu; Donghao Li; Zhuang Wang; Chi Zhang; Yuguo Li; Shuang Liang; Haimiao Yang; Lei Gao

Copyright © 2026 Liu, Lu, Li, Wang, Zhang, Li, Liang, Yang and Gao.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D supplementation may reduce asthma exacerbations and appears to be safe as an adjunctive treatment, but current evidence does not consistently support improvements in daily symptom control, lung function, or inflammatory outcomes. These findings should be interpreted cautiously because of heterogeneity, evidence uncertainty, and overlap among primary studies. Future studies should identify patients most likely to benefit and clarify optimal dose, duration, and biomarker-guided supplementation strategies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This umbrella review aimed to evaluate the efficacy and safety of vitamin D supplementation as an adjunctive treatment for asthma and to assess the credibility of the existing evidence.

Source: Objective

Abstract: What methods does the paper describe?

We systematically searched PubMed, Cochrane Library, Web of Science, Embase, CNKI, WANFANG, VIP, and CBM from inception to November 26, 2025. Published systematic reviews and meta-analyses evaluating vitamin D supplementation for asthma were included. We assessed methodological quality, risk of bias, reporting quality, certainty of evidence, and overlap among primary studies using standard appraisal tools.

Source: Methods

Abstract: Systematic review registration

Abstract: Results

21 systematic reviews and meta-analyses were included. Overlap among primary studies was substantial. Vitamin D supplementation was associated with a lower risk of asthma exacerbations, but its effects on asthma control, lung function, and inflammatory outcomes were limited or inconsistent. No significant increase in adverse events was observed. The certainty of evidence varied across outcomes, and many findings were supported by low or very low certainty evidence.

Source: Results

Abstract: Conclusion

Vitamin D supplementation may reduce asthma exacerbations and appears to be safe as an adjunctive treatment, but current evidence does not consistently support improvements in daily symptom control, lung function, or inflammatory outcomes. These findings should be interpreted cautiously because of heterogeneity, evidence uncertainty, and overlap among primary studies. Future studies should identify patients most likely to benefit and clarify optimal dose, duration, and biomarker-guided supplementation strategies.

Source: Conclusion
Authors’ abstract

Background

Asthma is a common chronic airway disease that can cause recurrent symptoms, acute exacerbations, impaired quality of life, and substantial healthcare burden. Vitamin D has been proposed as a potential add-on therapy because of its roles in immune regulation and respiratory defense, but its clinical benefits in asthma remain uncertain.

Objective

This umbrella review aimed to evaluate the efficacy and safety of vitamin D supplementation as an adjunctive treatment for asthma and to assess the credibility of the existing evidence.

Methods

We systematically searched PubMed, Cochrane Library, Web of Science, Embase, CNKI, WANFANG, VIP, and CBM from inception to November 26, 2025. Published systematic reviews and meta-analyses evaluating vitamin D supplementation for asthma were included. We assessed methodological quality, risk of bias, reporting quality, certainty of evidence, and overlap among primary studies using standard appraisal tools.

Results

21 systematic reviews and meta-analyses were included. Overlap among primary studies was substantial. Vitamin D supplementation was associated with a lower risk of asthma exacerbations, but its effects on asthma control, lung function, and inflammatory outcomes were limited or inconsistent. No significant increase in adverse events was observed. The certainty of evidence varied across outcomes, and many findings were supported by low or very low certainty evidence.

Conclusion

Vitamin D supplementation may reduce asthma exacerbations and appears to be safe as an adjunctive treatment, but current evidence does not consistently support improvements in daily symptom control, lung function, or inflammatory outcomes. These findings should be interpreted cautiously because of heterogeneity, evidence uncertainty, and overlap among primary studies. Future studies should identify patients most likely to benefit and clarify optimal dose, duration, and biomarker-guided supplementation strategies.

Systematic review registration

https://www.crd.york.ac.uk/PROSPERO/view/CRD420251239612, identifier: CRD420251239612.

Publication and source details

Original title: Efficacy and safety of vitamin D in the treatment of asthma: an overview of systematic reviews and meta-analyses

Yongxiu Liu; Jiaheng Lu; Donghao Li; Zhuang Wang; Chi Zhang; Yuguo Li; Shuang Liang; Haimiao Yang; Lei Gao

Frontiers in Medicine · 2026

* Correspondence: Haimiao Yang, 315597629@qq.com; Lei Gao, gaolei790708@163.comCopyright © 2026 Liu, Lu, Li, Wang, Zhang, Li, Liang, Yang and Gao.2026Liu, Lu, Li, Wang, Zhang, Li, Liang, Yang and Gaohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:29:00.079452+00:00

DOI: 10.3389/fmed.2026.1783005 · PMC13246613